Compare Stocks: JAGX vs. APVO vs. MLEC vs. GRI
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
JAGXAPVOMLECGRI
Market Snapshot
Current market context for the selected companies.
JAGX
$0.92
Market Cap
$4.78M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
APVO
$2.46
Market Cap
$4.43M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
MLEC
$6.81
Market Cap
$5.21M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
GRI
$1.92
Market Cap
$4.28M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | JAGX | APVO | MLEC | GRI |
|---|---|---|---|---|
| 1 Month | -4.9% | -41.6% | -6.3% | +34.3% |
| 1 Month vs SPY | -8.2% | -44.9% | -9.6% | +30.9% |
| 3 Months | -71.3% | -49.2% | -6.1% | -8.6% |
| 3 Months vs SPY | -73.3% | -51.2% | -8.1% | -10.6% |
| 6 Months | -97.0% | -65.7% | -57.8% | -22.9% |
| 6 Months vs SPY | -107.4% | -76.1% | -68.2% | -33.3% |
| 1 Year | -98.5% | -92.8% | -70.3% | -95.2% |
| 1 Year vs SPY | -117.7% | -112.0% | -89.5% | -114.4% |
| 2 Years | -99.9% | -100.0% | -94.8% | -99.2% |
| 2 Years vs SPY | -136.5% | -136.5% | -131.4% | -135.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.